Can weight loss improve migraine headaches in obese women? Rationale and design of the Women's Health and Migraine (WHAM) randomized controlled trial

Dale S. Bond, Kevin C. O'Leary, J. Graham Thomas, Richard B. Lipton, George D. Papandonatos, Julie Roth, Lucille Rathier, Richard Daniello, Rena R. Wing

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background: Research demonstrates a link between migraine and obesity. Obesity increases the risk of frequent migraines and is associated with migraine prevalence among reproductive-aged women. These findings are substantiated by several plausible mechanisms and emerging evidence of migraine improvements after surgical and non-surgical weight loss. However, no previous study has examined the effect of weight loss on migraine within a treatment-controlled framework. The WHAM trial is an RCT to test the efficacy of behavioral weight loss as a treatment for migraine. Study design: Overweight/obese women (n=140; BMI=25.0-49.9kg/m2) who meet international diagnostic criteria for migraine and record ≥3 migraines and 4-20 migraine days using a smartphone-based headache diary during a 4-week baseline period, will be randomly assigned to 4months of either group-based behavioral weight loss (intervention) or migraine education (control). Intervention participants will be taught strategies to increase physical activity and consume fewer calories in order to lose weight. Control participants will receive general education on migraine symptoms/triggers and various treatment approaches. Both groups will use smartphones to record their headaches for 4weeks at baseline, after the 16-week treatment period, and at the end of a 16-week follow-up period. Changes in weight and other potential physiological (inflammation), psychological (depression), and behavioral (diet and physical activity) mediators of the intervention effect will also be assessed. Conclusion: The WHAM trial will evaluate the efficacy of a standardized behavioral weight loss intervention for reducing migraine frequency, and the extent to which weight loss and other potential mediators account for intervention effects.

Original languageEnglish (US)
Pages (from-to)133-144
Number of pages12
JournalContemporary Clinical Trials
Volume35
Issue number1
DOIs
StatePublished - May 2013

Fingerprint

Women's Health
Migraine Disorders
Weight Loss
Randomized Controlled Trials
Headache
Obesity
Exercise
Education
Weights and Measures
Therapeutics

Keywords

  • Headache
  • Migraine
  • Obesity
  • Randomized controlled trial
  • Weight loss

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Medicine(all)

Cite this

Can weight loss improve migraine headaches in obese women? Rationale and design of the Women's Health and Migraine (WHAM) randomized controlled trial. / Bond, Dale S.; O'Leary, Kevin C.; Thomas, J. Graham; Lipton, Richard B.; Papandonatos, George D.; Roth, Julie; Rathier, Lucille; Daniello, Richard; Wing, Rena R.

In: Contemporary Clinical Trials, Vol. 35, No. 1, 05.2013, p. 133-144.

Research output: Contribution to journalArticle

Bond, Dale S. ; O'Leary, Kevin C. ; Thomas, J. Graham ; Lipton, Richard B. ; Papandonatos, George D. ; Roth, Julie ; Rathier, Lucille ; Daniello, Richard ; Wing, Rena R. / Can weight loss improve migraine headaches in obese women? Rationale and design of the Women's Health and Migraine (WHAM) randomized controlled trial. In: Contemporary Clinical Trials. 2013 ; Vol. 35, No. 1. pp. 133-144.
@article{ae76285d9e4e4909b97c328307512372,
title = "Can weight loss improve migraine headaches in obese women? Rationale and design of the Women's Health and Migraine (WHAM) randomized controlled trial",
abstract = "Background: Research demonstrates a link between migraine and obesity. Obesity increases the risk of frequent migraines and is associated with migraine prevalence among reproductive-aged women. These findings are substantiated by several plausible mechanisms and emerging evidence of migraine improvements after surgical and non-surgical weight loss. However, no previous study has examined the effect of weight loss on migraine within a treatment-controlled framework. The WHAM trial is an RCT to test the efficacy of behavioral weight loss as a treatment for migraine. Study design: Overweight/obese women (n=140; BMI=25.0-49.9kg/m2) who meet international diagnostic criteria for migraine and record ≥3 migraines and 4-20 migraine days using a smartphone-based headache diary during a 4-week baseline period, will be randomly assigned to 4months of either group-based behavioral weight loss (intervention) or migraine education (control). Intervention participants will be taught strategies to increase physical activity and consume fewer calories in order to lose weight. Control participants will receive general education on migraine symptoms/triggers and various treatment approaches. Both groups will use smartphones to record their headaches for 4weeks at baseline, after the 16-week treatment period, and at the end of a 16-week follow-up period. Changes in weight and other potential physiological (inflammation), psychological (depression), and behavioral (diet and physical activity) mediators of the intervention effect will also be assessed. Conclusion: The WHAM trial will evaluate the efficacy of a standardized behavioral weight loss intervention for reducing migraine frequency, and the extent to which weight loss and other potential mediators account for intervention effects.",
keywords = "Headache, Migraine, Obesity, Randomized controlled trial, Weight loss",
author = "Bond, {Dale S.} and O'Leary, {Kevin C.} and Thomas, {J. Graham} and Lipton, {Richard B.} and Papandonatos, {George D.} and Julie Roth and Lucille Rathier and Richard Daniello and Wing, {Rena R.}",
year = "2013",
month = "5",
doi = "10.1016/j.cct.2013.03.004",
language = "English (US)",
volume = "35",
pages = "133--144",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Can weight loss improve migraine headaches in obese women? Rationale and design of the Women's Health and Migraine (WHAM) randomized controlled trial

AU - Bond, Dale S.

AU - O'Leary, Kevin C.

AU - Thomas, J. Graham

AU - Lipton, Richard B.

AU - Papandonatos, George D.

AU - Roth, Julie

AU - Rathier, Lucille

AU - Daniello, Richard

AU - Wing, Rena R.

PY - 2013/5

Y1 - 2013/5

N2 - Background: Research demonstrates a link between migraine and obesity. Obesity increases the risk of frequent migraines and is associated with migraine prevalence among reproductive-aged women. These findings are substantiated by several plausible mechanisms and emerging evidence of migraine improvements after surgical and non-surgical weight loss. However, no previous study has examined the effect of weight loss on migraine within a treatment-controlled framework. The WHAM trial is an RCT to test the efficacy of behavioral weight loss as a treatment for migraine. Study design: Overweight/obese women (n=140; BMI=25.0-49.9kg/m2) who meet international diagnostic criteria for migraine and record ≥3 migraines and 4-20 migraine days using a smartphone-based headache diary during a 4-week baseline period, will be randomly assigned to 4months of either group-based behavioral weight loss (intervention) or migraine education (control). Intervention participants will be taught strategies to increase physical activity and consume fewer calories in order to lose weight. Control participants will receive general education on migraine symptoms/triggers and various treatment approaches. Both groups will use smartphones to record their headaches for 4weeks at baseline, after the 16-week treatment period, and at the end of a 16-week follow-up period. Changes in weight and other potential physiological (inflammation), psychological (depression), and behavioral (diet and physical activity) mediators of the intervention effect will also be assessed. Conclusion: The WHAM trial will evaluate the efficacy of a standardized behavioral weight loss intervention for reducing migraine frequency, and the extent to which weight loss and other potential mediators account for intervention effects.

AB - Background: Research demonstrates a link between migraine and obesity. Obesity increases the risk of frequent migraines and is associated with migraine prevalence among reproductive-aged women. These findings are substantiated by several plausible mechanisms and emerging evidence of migraine improvements after surgical and non-surgical weight loss. However, no previous study has examined the effect of weight loss on migraine within a treatment-controlled framework. The WHAM trial is an RCT to test the efficacy of behavioral weight loss as a treatment for migraine. Study design: Overweight/obese women (n=140; BMI=25.0-49.9kg/m2) who meet international diagnostic criteria for migraine and record ≥3 migraines and 4-20 migraine days using a smartphone-based headache diary during a 4-week baseline period, will be randomly assigned to 4months of either group-based behavioral weight loss (intervention) or migraine education (control). Intervention participants will be taught strategies to increase physical activity and consume fewer calories in order to lose weight. Control participants will receive general education on migraine symptoms/triggers and various treatment approaches. Both groups will use smartphones to record their headaches for 4weeks at baseline, after the 16-week treatment period, and at the end of a 16-week follow-up period. Changes in weight and other potential physiological (inflammation), psychological (depression), and behavioral (diet and physical activity) mediators of the intervention effect will also be assessed. Conclusion: The WHAM trial will evaluate the efficacy of a standardized behavioral weight loss intervention for reducing migraine frequency, and the extent to which weight loss and other potential mediators account for intervention effects.

KW - Headache

KW - Migraine

KW - Obesity

KW - Randomized controlled trial

KW - Weight loss

UR - http://www.scopus.com/inward/record.url?scp=84876301920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876301920&partnerID=8YFLogxK

U2 - 10.1016/j.cct.2013.03.004

DO - 10.1016/j.cct.2013.03.004

M3 - Article

C2 - 23524340

AN - SCOPUS:84876301920

VL - 35

SP - 133

EP - 144

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

IS - 1

ER -